Suchergebnisse - "Subramanian, Sreedhar"

PubPharm (9)

1

Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13] : A Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2022

von Smith, P. | Critchley, L. | Storey, D. | +17

2

Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease : long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource

enthalten in: Gut | 2021

von Stournaras, E. | Qian, W. | Pappas, A. | +106

CommentIn: Gut. 2021 Jul;70(7):1416-1418. - PMID 32928916

3

From intravenous to subcutaneous infliximab in patients with inflammatory bowel disease : a pandemic-driven initiative

enthalten in: The lancet. Gastroenterology & hepatology | 2021

von Verma, A. | Patel, A. | Subramanian, S. | +1

4

IBD BioResource : an open-access platform of 25 000 patients to accelerate research in Crohn's and Colitis

enthalten in: Gut | 2019

von Parkes, M. | IBD BioResource Investigators | Abdelmalek, E. | +99

5

Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitis

enthalten in: European journal of gastroenterology & hepatology | 2019

von Davis, R. | McParland, P. | Dodd, S. | +8

6

A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK : The REVIVE study

enthalten in: Medicine | 2019

von Cummings, F. | Gaya, D. | Levison, S. | +7

7

A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease : The Cross Pennine study

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2018

von Lenti, M. | Levison, S. | Eliadou, E. | +20

8

Recent advances in clinical practice : a systematic review of isolated colonic Crohn's disease: the third IBD?

enthalten in: Gut | 2017

von Subramanian, S. | Ekbom, A. | Rhodes, J.

9

Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent

enthalten in: Inflammatory bowel diseases | 2011

von Subramanian, S. | Yajnik, V. | Sands, B. | +2

1
[1]